Outcomes of idiopathic versus secondary nodular regenerative hyperplasia of the liver: A longitudinal study of 167 cases.

Daniel D Penrice Nimish ThakralCamille A KezerRyan LennonRoger K MoreiraRondell P GrahamPatrick S KamathDouglas A Simonetto

Published in: Liver international : official journal of the International Association for the Study of the Liver (2022)

The rates of liver-related complications and mortality in NRH are low, and only a small number of patients ultimately require liver transplantation. Most patients do not have an identified risk factor or aetiology for NRH, and liver-related outcomes do not appear to differ based on associated, possibly causal, conditions.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
risk factors
chronic kidney disease
stem cells
prognostic factors
cardiovascular events
patient reported outcomes
insulin resistance
drug induced